Earlier this month, more than 590,000 inhalers were recalled due to possible defects that could pose risks to users. GlaxoSmithKline is a drug company based in Britain which develops inhalers used by many United States citizens for asthma control. The company received customer complaints regarding packaging and leakage, which led to concern over the amount of Ventolin the devices will deliver. If an inhaler were to leak, it could cause it to produce a lower dosage than indicated when users need it.
While no injuries or illnesses have been reported because of this defect, the British drug maker is requesting that the inhalers be removed from pharmacies, hospitals, wholesalers and retailers immediately. Patients, however, are not being required to return their inhalers. At this time, the company is simply researching whether an issue exists with the inhalers, as well as how to correct it if so.
The recall affects several Ventolin HFA 200D inhalers with lot numbers 6ZP9944, 6ZP9848 and 6ZP0003.
Asthma is a very common problem in the United States. Many people carry an inhaler with them everywhere they go, simply as a precaution. But what if that device fails to work as described? An ineffective inhaler can be the difference between life and death. So make sure you understand how to best use your inhaler and check for recalls regularly.